Guidance for the management of adult patients with coronavirus disease 2019
Open Access
- 28 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 133 (13) , 1575-1594
Abstract
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.Keywords
This publication has 61 references indexed in Scilit:
- Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDSIntensive Care Medicine, 2013
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid ArthritisNew England Journal of Medicine, 2012
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Relationship between anxiety and dyspnea on exertion in patients with chronic obstructive pulmonary diseaseAnxiety, stress, and coping, 2011
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patientsRheumatology, 2010
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Lung Recruitment in Patients with the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2006
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compoundsJournal of Clinical Virology, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004